Sai Life Sciences Limited

Sai Life Sciences Limited (SAILIFE) is a mid-cap Healthcare company valued at ₹29,505 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Sai Life Sciences Limited last traded at ₹1,388.9, modestly down 0.42% on the day.

Recent developments

On 2026-06-25, the company was highlighted as part of India's CDMO industry poised for global growth as pharma companies diversify away from China, with investments in capacity expected to drive expansion.

Financial performance

The company's business is improving, with annual revenue rising 29.4% and annual net profit surging 105.2%. The latest quarter saw revenue grow 11.8% compared to the same quarter a year earlier, while net profit increased 22.2%.

Valuation multiples

The stock trades at 83.5 times earnings, a premium to the Healthcare median of 32.0, 13.62 times book value.

Things to watch

The stock is 12.3% below its 52-week high, and the company does not pay dividends despite reporting consistent profits. Promoter holding remains stable at 34.50%, but domestic institutional holding fell by 0.39 points in the quarter.

Where it stands

Sai Life Sciences has shown strong revenue and profit growth over the past year and quarter, with net margins expanding significantly. The stock's recent performance and sector positioning suggest continued growth potential, though its current price is below its 52-week high.

Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.